1. Baehring JM, Damek D, Martin EC, Betensky RA, Hochberg FH. Neurolymphomatosis. Neuro Oncol. 2003. 5:104–115.
Article
2. Byun WM, Park WK, Park BH, Ahn SH, Hwang MS, Chang JC. Guillain-Barré syndrome: MR imaging findings of the spine in eight patients. Radiology. 1998. 208:137–141.
Article
3. Currie S, Henson RA. Neurological syndromes in the reticuloses. Brain. 1971. 94:307–320.
Article
4. Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J. Lymphoma classification--from controversy to consensus: the R.E.A.L. and WHO Classification of lymphoid neoplasms. Ann Oncol. 2000. 11:Suppl 1. 3–10.
5. Hoerni-Simon G, Suchaud JP, Eghbali H, Coindre JM, Hoerni B. Secondary involvement of the central nervous system in malignant non-Hodgkin's lymphoma. A study of 30 cases in a series of 498 patients. Oncology. 1987. 44:98–101.
6. Kajiya Y, Nakajo M, Kajiya Y, Miyaji N. Oculomotor nerve invasion by lymphoma demonstrated by MRI. J Comput Assist Tomogr. 1995. 19:502–504.
Article
7. Manon-Espaillat R, Lanska DJ, Ruff RL, Masaryk T. Visualization of isolated trigeminal nerve invasion by lymphoma using gadolinium-enhanced magnetic resonance imaging. Neuroradiology. 1990. 32:531–532.
Article
8. Recht LD. Neurologic complications of systemic lymphoma. Neurol Clin. 1991. 9:1001–1015.
Article
9. Richmond J, Sherman RS, Diamond HD, Craver LF. Renal lesions associated with malignant lymphomas. Am J Med. 1962. 32:184–207.
Article
10. Young RC, Howser DM, Anderson T, Fisher RI, Jaffe E, DeVita VT. Central nervous system complications of non-Hodgkin's lymphoma. The potential role for prophylactic therapy. Am J Med. 1979. 66:435–443.